Preventive Cardiovascular

Impact of Preventive Cardiology on HgbA1c Levels Among Patients With Diabetes

Impact of Preventive Cardiology on HgbA1c Levels in Diabetic Patients

2016 – 2020, N = 161

Preventive cardiology patients who are diabetic and had an HgbA1c level of 7% or higher at baseline experienced reductions in their HgbA1c levels. Baseline is defined as the patient's first visit. Follow-up data are from the most recent visit. Patients included in these data had at least 2 follow-up visits in the past 2 years.

Source: EPIC

The data for 2019 is reflective of the last 6 months of 2019. Lab values were somewhat limited in 2020 due to COVID-19. Fluctuations in 2020 volumes are a result of significant changes to the number of patients treated, which can be directly attributed to the COVID-19 pandemic.